The Patent Finder

Prophy Med AB

Also on record
Records under this name other than patents Prophy Med AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Prophy Med AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,629,123Use of dextran sulfate
Formerly held
Lapsed on the fee record
Ended Jan 14, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 14, 2026USPTO record
US 8,906,884Method of treating graft-rejection using dextran sulfate
Formerly held
Term ended
Term ended Aug 17, 2025 · USPTO record
Term endedTerm ended Aug 17, 2025USPTO record
US 8,784,845Selective chemokine modulation
Lapsed on the fee record
Ended Jul 22, 2022 · USPTO record
Lapsed on the fee recordEnded Jul 22, 2022USPTO record
US 9,656,015Selective chemokine modulation
Lapsed on the fee record
Ended May 23, 2021 · USPTO record
Lapsed on the fee recordEnded May 23, 2021USPTO record
US 9,649,426Selective chemokine modulation
Lapsed on the fee record
Ended May 16, 2021 · USPTO record
Lapsed on the fee recordEnded May 16, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited